- Investing Ideas
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
6
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
6 companies
argenx
Market Cap: €41.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€670.80
7D
0.4%
1Y
35.2%
Elia Group
Market Cap: €15.0b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€136.20
7D
-3.7%
1Y
45.0%
Groupe Bruxelles Lambert
Market Cap: €9.8b
Invests in a portfolio of industrial, consumer goods, and business service companies in Belgium, other European countries, North America, and internationally.
GBLB
€81.15
7D
2.1%
1Y
16.1%
UCB
Market Cap: €44.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€234.10
7D
1.3%
1Y
51.7%
Lotus Bakeries
Market Cap: €8.7b
Provides various snack products in Belgium and internationally.
LOTB
€10,720.00
7D
4.5%
1Y
22.9%
D'Ieteren Group
Market Cap: €9.4b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€177.80
7D
1.3%
1Y
-0.9%